We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Multimodal Therapy Approaches for NUT Carcinoma by Dual Combination of Oncolytic Virus Talimogene Laherparepvec with Small Molecule Inhibitors.
- Authors
Sotiriadis, Stavros; Beil, Julia; Berchtold, Susanne; Smirnow, Irina; Schenk, Andrea; Lauer, Ulrich M.
- Abstract
NUT (nuclear-protein-in-testis) carcinoma (NC) is a highly aggressive tumor disease. Given that current treatment regimens offer a median survival of six months only, it is likely that this type of tumor requires an extended multimodal treatment approach to improve prognosis. In an earlier case report, we could show that an oncolytic herpes simplex virus (T-VEC) is functional in NC patients. To identify further combination partners for T-VEC, we have investigated the anti-tumoral effects of T-VEC and five different small molecule inhibitors (SMIs) alone and in combination in human NC cell lines. Dual combinations were found to result in higher rates of tumor cell reductions when compared to the respective monotherapy as demonstrated by viability assays and real-time tumor cell growth monitoring. Interestingly, we found that the combination of T-VEC with SMIs resulted in both stronger and earlier reductions in the expression of c-Myc, a main driver of NC cell proliferation, when compared to T-VEC monotherapy. These results indicate the great potential of combinatorial therapies using oncolytic viruses and SMIs to control the highly aggressive behavior of NC cancers and probably will pave the way for innovative multimodal clinical studies in the near future.
- Subjects
COMBINED modality therapy; SMALL molecules; ONCOLYTIC virotherapy; HERPES simplex virus; CARCINOMA
- Publication
Viruses (1999-4915), 2024, Vol 16, Issue 5, p775
- ISSN
1999-4915
- Publication type
Article
- DOI
10.3390/v16050775